The DOI matches its Crossref record; 159 of the 159 references it cites were found in a registry or an index.
Evaluation of human intestinal absorption data and subsequent derivation of a quantitative structure–activity relationship (QSAR) with the Abraham descriptors
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,385
Computer Aided Design of Experiments
Kennard, R. W., & Stone, L. A. (1969) · Technometrics · doi:10.1080/00401706.1969.10490666 · Cited by 3,648
The Pharmacological Basis of Therapeutics
Goodman, L., & Gilhan, A. (1941) · Anesthesiology · doi:10.1097/00000542-194105000-00013 · Cited by 2,146
Abraham, M. H. (1993) · Chemical Society Reviews · doi:10.1039/cs9932200073 · Cited by 1,968
Self-citationThe pharmacological basis of therapeutics
Starr, I. (1941) · American Heart Journal · doi:10.1016/s0002-8703(41)90958-4 · Cited by 1,902
Artursson, P., & Karlsson, J. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)91647-u · Cited by 1,893
Ward, A., & Clissold, S. P. (1987) · Drugs · doi:10.2165/00003495-198734010-00003 · Cited by 1,754
Analytical profiles of drug substances
(1975) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600640947 · Cited by 1,491
Kansy, M., Senner, F., & Gubernator, K. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm970530e · Cited by 1,304
Remington's pharmaceutical sciences
(1976) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600650641 · Cited by 1,136
Yee, S. (1997) · Pharmaceutical Research · doi:10.1023/a:1012102522787 · Cited by 1,030
MDCK (Madin-Darby Canine Kidney) Cells: A Tool for Membrane Permeability Screening
Irvine, J. D., Takahashi, L., Lockhart, K., Cheong, J., Tolan, J. W., Selick, H. E., & Grove, J. R. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js9803205 · Cited by 980
Polar Molecular Surface Properties Predict the Intestinal Absorption of Drugs in Humans
Palm, K., Stenberg, P., Luthman, K., & Artursson1, P. (1997) · Pharmaceutical Research · doi:10.1023/a:1012188625088 · Cited by 756
Clinical Pharmacokinetics of Metformin
Scheen, A. J. (1996) · Clinical Pharmacokinetics · doi:10.2165/00003088-199630050-00003 · Cited by 636
Clark, D. E. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js9804011 · Cited by 627
Lennernäs, H., & Fager, G. (1997) · Clinical Pharmacokinetics · doi:10.2165/00003088-199732050-00005 · Cited by 527
Metformin kinetics in healthy subjects and in patients with diabetes mellitus.
Tucker, G., Casey, C., Phillips, P., Connor, H., Ward, J., & Woods, H. (1981) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1981.tb01206.x · Cited by 497
Clinical Pharmacokinetics of Diazepam
Mandelli, M., Tognoni, G., & Garattini, S. (1978) · Clinical Pharmacokinetics · doi:10.2165/00003088-197803010-00005 · Cited by 496
Clinical Pharmacokinetics of Paracetamol
Forrest, J. A. H., Clements, J. A., & Prescott, L. F. (1982) · Clinical Pharmacokinetics · doi:10.2165/00003088-198207020-00001 · Cited by 493
Yazdanian, M., Glynn, S. L., Wright, J. L., & Hawi, A. (1998) · Pharmaceutical Research · doi:10.1023/a:1011930411574 · Cited by 453
Winiwarter, S., Bonham, N. M., Ax, F., Hallberg, A., Lennernäs, H., & Karlén, A. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm9810102 · Cited by 453
Estimation of Molecular Linear Free Energy Relation Descriptors Using a Group Contribution Approach
Platts, J. A., Butina, D., Abraham, M. H., & Hersey, A. (1999) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci980339t · Cited by 441
Self-citationWacher, V. J., Silverman, J. A., Zhang, Y., & Benet, L. Z. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js980082d · Cited by 423
Clinical Pharmacokinetics of Doxorubicin
Speth, P. A. J., van Hoesel, Q. G. C. M., & Haanen, C. (1988) · Clinical Pharmacokinetics · doi:10.2165/00003088-198815010-00002 · Cited by 420
Correlation of Drug Absorption with Molecular Surface Properties
Palm, K., Luthman, K., Unge, A.-L., Strandlund, G., & Artursson, P. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js950285r · Cited by 412
Clinical Pharmacokinetics of Diclofenac: Therapeutic Insights and Pitfalls
Davies, N. M., & Anderson, K. E. (1997) · Clinical Pharmacokinetics · doi:10.2165/00003088-199733030-00003 · Cited by 398
Klecker, R. W., Collins, J. M., Yarchoan, R., Thomas, R., Jenkins, J. F., Broder, S., & Myers, C. E. (1987) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1987.49 · Cited by 381
THE PHYSIOLOGICAL DISPOSITION AND METABOLIC FATE OF HYDROCORTISONE IN MAN
Peterson, R. E., Wyngaarden, J. B., Guerra, S. L., Brodie, B. B., & Bunim, J. J. (1955) · Journal of Clinical Investigation · doi:10.1172/jci103233 · Cited by 371
Prediction of Human Intestinal Absorption of Drug Compounds from Molecular Structure
Wessel, M. D., Jurs, P. C., Tolan, J. W., & Muskal, S. M. (1998) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci980029a · Cited by 365
Holford, N. H. G. (1986) · Clinical Pharmacokinetics · doi:10.2165/00003088-198611060-00005 · Cited by 360
Cyclosporin Clinical Pharmacokinetics
Fahr, A. (1993) · Clinical Pharmacokinetics · doi:10.2165/00003088-199324060-00004 · Cited by 356
Clinical Pharmacokinetics of H1-Receptor Antagonists (The Antihistamines)
Paton, D. M., & Webster, D. R. (1985) · Clinical Pharmacokinetics · doi:10.2165/00003088-198510060-00002 · Cited by 334
Brogden, R. N., Todd, P. A., & Sorkin, E. M. (1988) · Drugs · doi:10.2165/00003495-198836050-00003 · Cited by 318
Pharmacokinetic Changes During Pregnancy and Their Clinical Relevance
Loebstein, R., Lalkin, A., & Koren, G. (1997) · Clinical Pharmacokinetics · doi:10.2165/00003088-199733050-00002 · Cited by 314
Stewart, B. H., Kugler, A. R., Thompson, P. R., & Bockbrader, H. N. (1993) · Pharmaceutical Research · doi:10.1023/a:1018951214146 · Cited by 309
Influence of food and diet on gastrointestinal drug absorption: A review
Welling, P. G. (1977) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01061694 · Cited by 307
Pharmacokinetics of Opioids in Liver Disease
Tegeder, I., L??tsch, J., & Geisslinger, G. (1999) · Clinical Pharmacokinetics · doi:10.2165/00003088-199937010-00002 · Cited by 306
Clinical Pharmacokinetics of the Antiviral Nucleotide Analogues Cidofovir and Adefovir
Cundy, K. C. (1999) · Clinical Pharmacokinetics · doi:10.2165/00003088-199936020-00004 · Cited by 303
Abraham, M. H., & Le, J. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js9901007 · Cited by 302
Self-citationClinical Pharmacokinetics of Morphine
Glare, P. A., & Walsh, T. D. (1991) · Therapeutic Drug Monitoring · doi:10.1097/00007691-199101000-00001 · Cited by 290
The effects of ketoconazole on the intestinal metabolism and bioavailability of cyclosporine*
Gomez, D. Y., Wacher, V. J., Tomlanovich, S. J., Hebert, M. F., & Benet, L. Z. (1995) · Clinical Pharmacology & Therapeutics · doi:10.1016/0009-9236(95)90067-5 · Cited by 282
Clinical Pharmacokinetics of Lamivudine
Johnson, M. A., Moore, K. H. P., Yuen, G. J., Bye, A., & Pakes, G. E. (1999) · Clinical Pharmacokinetics · doi:10.2165/00003088-199936010-00004 · Cited by 275
Liposomal and Lipid Formulations of Amphotericin B: Clinical Pharmacokinetics
Janknegt, R., de Marie, S., Bakker-Woudenberg, I. A. J. M., & Crommelin, D. J. A. (1992) · Clinical Pharmacokinetics · doi:10.2165/00003088-199223040-00004 · Cited by 274
The clinical importance of cardioselectivity and lipophilicity in beta blockers
Cruickshank, J. M. (1980) · American Heart Journal · doi:10.1016/0002-8703(80)90112-x · Cited by 264
The Clinical Pharmacology of Etoposide and Teniposide
Clark, P. I., & Slevin, M. L. (1987) · Clinical Pharmacokinetics · doi:10.2165/00003088-198712040-00001 · Cited by 263
Linear Correlation of the Fraction of Oral Dose Absorbed of 64 Drugs Between Humans and Rats
Chiou, W. L., & Barve, A. (1998) · Pharmaceutical Research · doi:10.1023/a:1011981317451 · Cited by 257
WHITWAM, J. G., & AMREIN, R. (1995) · Acta Anaesthesiologica Scandinavica · doi:10.1111/j.1399-6576.1995.tb04374.x · Cited by 257
Stereoselective disposition of ibuprofen enantiomers in man.
Lee, E., Williams, K., Day, R., Graham, G., & Champion, D. (1985) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1985.tb02694.x · Cited by 257
Clinical Pharmacokinetics of Fluconazole
Debruyne, D., & Ryckelynck, J.-P. (1993) · Clinical Pharmacokinetics · doi:10.2165/00003088-199324010-00002 · Cited by 255
Pharmacokinetics and concentration‐effect relationships of intravenous and oral clonidine
Davies, D. S., Wing, L. M. H., Reid, J. L., Neill, E., Tippett, P., & Dollery, C. T. (1977) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1977215593 · Cited by 250
The Clinical Pharmacology, Pharmacokinetics and Metabolism of Sumatriptan
Fowler, P. A., Lacey, L. F., Thomas, M., Keene, O. N., Tanner, R. J. N., & Baber, N. S. (1991) · European Neurology · doi:10.1159/000116756 · Cited by 244
Improved method for estimating water solubility from octanol/water partition coefficient
Meylan, W. M., Howard, P. H., & Boethling, R. S. (1996) · Environmental Toxicology and Chemistry · doi:10.1002/etc.5620150205 · Cited by 240
Wiseman, L. R., & Faulds, D. (1994) · Drugs · doi:10.2165/00003495-199447010-00008 · Cited by 238
Effects of Liver Disease on Pharmacokinetics: An Update
Rodighiero, V. (1999) · Clinical Pharmacokinetics · doi:10.2165/00003088-199937050-00004 · Cited by 235
Clinical Pharmacokinetics of Ketoprofen and Its Enantiomers
Jamali, F., & Brocks, D. R. (1990) · Clinical Pharmacokinetics · doi:10.2165/00003088-199019030-00004 · Cited by 222
Absorption Potential: Estimating the Fraction Absorbed for Orally Administered Compounds
Dressman, J. B., Amidon, G. L., & Fleisher, D. (1985) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600740523 · Cited by 221
Stereoselective disposition of ibuprofen enantiomers in infants.
Rey, E., Pariente‐Khayat, A., Gouyet, L., Vauzelle‐Kervroedan, F., Pons, G., D'Athis, P., Dubois, M., Murat, I., Lassale, C., & Goehrs, M. (1994) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1994.tb04369.x · Cited by 212
Maxton, D. G., Bjarnason, I., Reynolds, A. P., Catt, S. D., Peters, T. J., & Menzies, I. S. (1986) · Clinical Science · doi:10.1042/cs0710071 · Cited by 204
Pharmacokinetics and bioavailability of sodium valproate
Klotz, U., & Antonin, K. H. (1977) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1977216736 · Cited by 202
Benet, L. Z., Wu, C.-Y., Hebert, M. F., & Wacher, V. J. (1996) · Journal of Controlled Release · doi:10.1016/0168-3659(95)00147-6 · Cited by 198
Ukabam, S. O., Clamp, J. R., & Cooper, B. T. (1983) · Digestion · doi:10.1159/000198932 · Cited by 189
Platts, J. A., Abraham, M. H., Butina, D., & Hersey, A. (2000) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci990427t · Cited by 181
Self-citationSinghvi, S., Pan, H., Morrison, R., & Willard, D. (1990) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1990.tb03626.x · Cited by 179
Predicting Fraction Dose Absorbed in Humans Using a Macroscopic Mass Balance Approach
Sinko, P. J., Leesman, G. D., & Amidon, G. L. (1991) · Pharmaceutical Research · doi:10.1023/a:1015892621261 · Cited by 178
Pharmacokinetics of Fluvastatin After Single and Multiple Doses in Normal Volunteers
Tse, F. L. S., Jaffe, J. M., & Troendle, A. (1992) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1992.tb05773.x · Cited by 175
Ondansetron Clinical Pharmacokinetics
Roila, F., & Del Favero, A. (1995) · Clinical Pharmacokinetics · doi:10.2165/00003088-199529020-00004 · Cited by 173
Gender-based effects on methylprednisolone pharmacokinetics and pharmacodynamics
Lew, K. H., Ludwig, E. A., Milad, M. A., Donovan, K., Jr., E. M., Ferry, J. J., & Jusko, W. J. (1993) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1993.167 · Cited by 169
Clinical Pharmacokinetics of Clonidine
Lowenthal, D. T., Matzek, K. M., & MacGregor, T. R. (1988) · Clinical Pharmacokinetics · doi:10.2165/00003088-198814050-00002 · Cited by 162
Azithromycin Clinical Pharmacokinetics
Lalak, N. J., & Morris, D. L. (1993) · Clinical Pharmacokinetics · doi:10.2165/00003088-199325050-00003 · Cited by 155
Pharmacokinetics/pharmacodynamics of furosemide in man: A review
Benet, L. Z. (1979) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01059438 · Cited by 153
Pharmacokinetics of Captopril in Healthy Subjects and in Patients with Cardiovascular Diseases
Duchin, K. L., McKinstry, D. N., Cohen, A. I., & Migdalof, B. H. (1988) · Clinical Pharmacokinetics · doi:10.2165/00003088-198814040-00002 · Cited by 151
DISPOSITION OF NALOXONE-7,8-3H IN NORMAL AND NARCOTIC-DEPENDENT MEN
Fishman, J., Roffwarg, H. P., & HELLMAN, L. (1973) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)29707-5 · Cited by 143
Clinical Pharmacology of New Histamiine H1 Receptor Antagonists
Simons, F. E. R., & Simons, K. J. (1999) · Clinical Pharmacokinetics · doi:10.2165/00003088-199936050-00003 · Cited by 138
Spyker, D. A., Rugloski, R. J., Vann, R. L., et al. (1977) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.11.1.132 · Cited by 130
Lancaster, S. G., & Todd, P. A. (1988) · Drugs · doi:10.2165/00003495-198835060-00003 · Cited by 127
Guanabenz A Review of its Pharmacodynamic Properties and Therapeutic Efficacy in Hypertension
Holmes, B., Brogden, R. N., Heel, R. C., Speight, T. M., & Avery, G. S. (1983) · Drugs · doi:10.2165/00003495-198326030-00003 · Cited by 125
Pharmacokinetics of the Penicillins in Man
Barza, M. J., & Weinstein, L. (1976) · Clinical Pharmacokinetics · doi:10.2165/00003088-197601040-00004 · Cited by 125
The physiological disposition of lovastatin.
Duggan, D. E., Chen, I. W., Bayne, W. F., Halpin, R. A., Duncan, C. A., Schwartz, M. S., Stubbs, R. J., & Vickers, S. (1989) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08739-2 · Cited by 124
Comparative Pharmacokinetics of Antiviral Nucleoside Analogues
Morse, G. D., Shelton, M. J., & OʼDonnell, A. M. (1993) · Clinical Pharmacokinetics · doi:10.2165/00003088-199324020-00002 · Cited by 124
Absolute oral bioavailability of ciprofloxacin
Drusano, G. L., Standiford, H. C., Plaisance, K. I., Forrest, A., Leslie, J. L., & Caldwell, J. (1986) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.30.3.444 · Cited by 124
Absorption of Peptide and Peptidomimetic Drugs
Amidon, G. L., & Lee, H. J. (1994) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.34.040194.001541 · Cited by 124
Pharmacokinetics of quinidine in humans after intravenous, intramuscular and oral administration.
Greenblatt, D. J., Pfeifer, H. J., Ochs, H. R., Franke, K., MacLaughlin, D. S., Smith, T. W., & Koch‐Weser, J. (1977) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)30967-5 · Cited by 122
Pharmacokinetic evaluation in man of terbutaline given as separate enantiomers and as the racemate.
Borgström, L., Nyberg, L., Jonsson, S., Lindberg, C., & Paulson, J. (1989) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1989.tb05334.x · Cited by 121
Ranadive, S. A., Chen, A., & Serajuddin, A. T. M. (1992) · Pharmaceutical Research · doi:10.1023/a:1015823315983 · Cited by 119
Clinical Pharmacokinetic Properties of the Macrolide Antibiotics
Periti, P., Mazzei, T., Mini, E., & Novelli, A. (1989) · Clinical Pharmacokinetics · doi:10.2165/00003088-198916040-00001 · Cited by 118
Robertson, D., Wood, N., Everest, H., Monks, K., Waller, D., Renwick, A., & George, C. (1989) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1989.tb03506.x · Cited by 117
Bioavailability of oral dexamethasone
Duggan, D. E., Yeh, K. C., Matalia, N., Ditzler, C. A., & McMahon, F. G. (1975) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1975182205 · Cited by 116
Clinical pharmacokinetics of new antiepileptic drugs
Walker, M. C., & Patsalos, P. (1995) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(95)00021-6 · Cited by 114
Absorption of Orally Administered Neomycin and Kanamycin
Kunin, C. M., Chalmers, T. C., Leevy, C. M., Sebastyen, S. C., Lieber, C. S., & Finland, M. (1960) · New England Journal of Medicine · doi:10.1056/nejm196002252620802 · Cited by 114
Clinical Pharmacokinetics of Imipramine and Desipramine
Sallee, F. R., & Pollock, B. G. (1990) · Clinical Pharmacokinetics · doi:10.2165/00003088-199018050-00002 · Cited by 113
Clinical Pharmacokinetics of Non-Opiate Abused Drugs
Busto, U., Bendayan, R., & Sellers, E. M. (1989) · Clinical Pharmacokinetics · doi:10.2165/00003088-198916010-00001 · Cited by 111
Felodipine kinetics in healthy men
Edgar, B., Regårdh, C. G., Johnsson, G., Johansson, L., Lundborg, P. G., Löfberg, I., & Rönn, O. (1985) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1985.160 · Cited by 111
Prediction of Intestinal Drug Absorption Properties by Three-Dimensional Solubility Parameters
Breitkreutz, J. (1998) · Pharmaceutical Research · doi:10.1023/a:1011941319327 · Cited by 110
Small intestinal permeability to mannitol, lactulose, and polyethylene glycol 400 in celiac disease
Ukabam, S. O., & Cooper, B. T. (1984) · Digestive Diseases and Sciences · doi:10.1007/bf01318423 · Cited by 109
The absolute oral bioavailability of selected drugs.
Sietsema, W. K. (1989) · PubMed · Cited by 109
Clinical Pharmacokinetics of Vasodilators: Part I
Kirsten, R., Nelson, K., Kirsten, D., & Heintz, B. (1998) · Clinical Pharmacokinetics · doi:10.2165/00003088-199834060-00003 · Cited by 108
Pharmacokinetic Disposition of Quinolones in Human Body Fluids and Tissues
Sörgel, F., Jaehde, U., Naber, K. G., & Stephan, U. (1989) · Clinical Pharmacokinetics · doi:10.2165/00003088-198900161-00004 · Cited by 107
Clinical Pharmacokinetics of Nefazodone
Greene, D. S., & Barbhaiya, R. H. (1997) · Clinical Pharmacokinetics · doi:10.2165/00003088-199733040-00002 · Cited by 104
Findlay, J. W. A., Fleet, J. V. W., Smith, P., Butz, R. F., Hinton, M. L., Blum, M. R., & Schroeder, D. H. (1981) · European Journal of Clinical Pharmacology · doi:10.1007/bf00637513 · Cited by 103
Abraham, M. H., Platts, J. A., Hersey, A., Leo, A. J., & Taft, R. W. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js990008a · Cited by 102
Self-citationAbsorption prediction from physicochemical parameters
Krämer, S. D. (1999) · Pharmaceutical Science & Technology Today · doi:10.1016/s1461-5347(99)00188-1 · Cited by 101
Lennernäs, H., Ahrenstedt, Ö., & Ungell, A. ‐. (1994) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1994.tb04309.x · Cited by 101
Clinical Pharmacokinetics of Chloramphenicol and Chloramphenicol Succinate
Ambrose, P. J. (1984) · Clinical Pharmacokinetics · doi:10.2165/00003088-198409030-00004 · Cited by 97
Pharmacokinetics of Oral Antihyperglycaemic Agents in Patients with Renal Insufficiency
Harrower, A. D. B. (1996) · Clinical Pharmacokinetics · doi:10.2165/00003088-199631020-00003 · Cited by 97
Balfour, J. A. B., & Goa, K. L. (1991) · Drugs · doi:10.2165/00003495-199142030-00008 · Cited by 95
Cefuroxime - A new cephalosporin antibiotic.
O'Callaghan, C. H., SYKES, R. B., Ryan, D. M., Foord, R. D., & Muggleton, P. W. (1976) · The Journal of Antibiotics · doi:10.7164/antibiotics.29.29 · Cited by 93
Pharmacokinetic Optimisation of the Treatment of Neurocysticercosis
Sotelo, J., & Jung, H. (1998) · Clinical Pharmacokinetics · doi:10.2165/00003088-199834060-00006 · Cited by 91
Clinical Pharmacokinetics of Mibefradil
Welker, H. A., WILTSHIRE, H. R., & Bullingham, R. E. S. (1998) · Clinical Pharmacokinetics · doi:10.2165/00003088-199835060-00001 · Cited by 83
Clinical Pharmacokinetics of the Antiandrogens and Their Efficacy in Prostate Cancer
Mahler, C., Verhelst, J. A., & Denis, L. (1998) · Clinical Pharmacokinetics · doi:10.2165/00003088-199834050-00005 · Cited by 83
Pharmacokinetic Factors in the Modern Drug Treatment of Tuberculosis
Douglas, J. G., & McLeod, M. (1999) · Clinical Pharmacokinetics · doi:10.2165/00003088-199937020-00003 · Cited by 82
Ulm, E. H. (1983) · Drug Metabolism Reviews · doi:10.3109/03602538308991383 · Cited by 81
Handbook of Clinical Pharmacokinetic Data
Jack, D. B. (1992) · Palgrave Macmillan UK eBooks · doi:10.1007/978-1-349-22495-1 · Cited by 81
Clinical Pharmacokinetics of Vasodilators
Kirsten, R., Nelson, K., Kirsten, D., & Heintz, B. (1998) · Clinical Pharmacokinetics · doi:10.2165/00003088-199835010-00002 · Cited by 81
Clinical Pharmacokinetics of Drugs Used in the Treatment of Gastrointestinal Diseases (Part I)1
Lauritsen, K., Laursen, L. S., & Rask-Madsen, J. (1990) · Clinical Pharmacokinetics · doi:10.2165/00003088-199019010-00002 · Cited by 80
Use of a Caco-2 cell culture model for the characterization of intestinal absorption of antibiotics
Biganzoli, E. M., Cavenaghi, L., Rossi, R., Brunati, M. C., & Nolli, M. L. (1999) · Il Farmaco · doi:10.1016/s0014-827x(99)00069-5 · Cited by 80
Platts, J. A., & Abraham, M. H. (1999) · Environmental Science & Technology · doi:10.1021/es9906195 · Cited by 79
Self-citationPharmacokinetics of Digoxin and Main Metabolites/Derivatives in Healthy Humans
Hinderling, P. H., & Hartmann, D. (1991) · Therapeutic Drug Monitoring · doi:10.1097/00007691-199109000-00001 · Cited by 79
Pharmacokinetic Optimisation of Asthma Treatment
Taburet, A., & Schmit, B. (1994) · Clinical Pharmacokinetics · doi:10.2165/00003088-199426050-00006 · Cited by 77
Sumatriptan Clinical Pharmacokinetics
SCOTT, A. K. (1994) · Clinical Pharmacokinetics · doi:10.2165/00003088-199427050-00002 · Cited by 76
Oumada, F. Z., Rosés, M., Bosch, E., & Abraham, M. H. (1999) · Analytica Chimica Acta · doi:10.1016/s0003-2670(98)00787-9 · Cited by 72
Self-citationClinical Pharmacokinetics of Zidovudine
Acosta, E. P., Page, L. M., & Fletcher, C. V. (1996) · Clinical Pharmacokinetics · doi:10.2165/00003088-199630040-00001 · Cited by 70
Enalapril Clinical Pharmacokinetics and Pharmacokinetic-Pharmacodynamic Relationships
MacFadyen, R. J., Meredith, P., & Elliott, H. L. (1993) · Clinical Pharmacokinetics · doi:10.2165/00003088-199325040-00003 · Cited by 69
Disposition of sumatriptan in laboratory animals and humans.
Dixon, C. M., Saynor, D. A., Andrew, P. D., Oxford, J. M., Bradbury, A., & Tarbit, M. H. (1993) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08158-9 · Cited by 67
Pharmacokinetic comparison of pindolol with other beta-adrenoceptor-blocking agents
Meier, J. (1982) · American Heart Journal · doi:10.1016/0002-8703(82)90127-2 · Cited by 64
Ahr, H. J., Boberg, M., Krause, H., Maul, W., Müller, F. O., Ploschke, H. J., Weber, H., & Wünsche, C. (1989) · PubMed · Cited by 62
Absorption of Steroid Hormones from the Human Small Intestine1
Schedl, H. P., White, D., & Miller, D. L. (1965) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-25-10-1309 · Cited by 61
Stereoselective pharmacokinetics of oral and intravenous nitrendipine in healthy male subjects.
Soons, P. A., & Breimer, D. D. (1991) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1991.tb05606.x · Cited by 58
Pharmacokinetics of metolazone in normal subjects and in patients with cardiac or renal failure
Tilstone, W. J., Dargie, H. J., Dargie, E. N., et al. (1974) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1974162322 · Cited by 57
The pharmacokinetics of ethynylestradiol in the presence and absence of gestodene and desogestrel
Orme, M., Back, D. J., Ward, S. A., & Green, S. (1991) · Contraception · doi:10.1016/0010-7824(91)90069-r · Cited by 57
Kinetics and biotransformation of lormetazepam
Humpel, M., Nieuweboer, B., Milius, W., Hanke, H., & Wendt, H. (1980) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1980.220 · Cited by 57
Sugawara, M., Takekuma, Y., HarumiYamada, MichiyaKobayashi, Isek, K., & Miyazaki, K. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js970451q · Cited by 53
Bioavailability and pharmacokinetics of oxazepam
Sonne, J., Loft, S. H., D�ssing, M., Vollmer-Larsen, A., Olesen, K. L., Victor, M., Andreasen, F., & Andreasen, P. B. (1988) · European Journal of Clinical Pharmacology · doi:10.1007/bf00561369 · Cited by 52
THE METABOLISM OF 4-14C PREDNISOLONE
Vermeulen, A. (1959) · Journal of Endocrinology · doi:10.1677/joe.0.0180278 · Cited by 50
The Pharmacokinetics of Propylthiouracil
Kampmann, J. P., & Skovsted, L. (1974) · Acta Pharmacologica et Toxicologica · doi:10.1111/j.1600-0773.1974.tb00756.x · Cited by 49
Cayen, M. N. (1985) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(85)90028-2 · Cited by 48
Tse, F. L. S., & Jaffe, J. M. (1987) · European Journal of Clinical Pharmacology · doi:10.1007/bf00543970 · Cited by 48
Pharmacokinetics of propranolol
Borgström, L., Johansson, C.-G., Larsson, H., & Lenander, R. (1981) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01060886 · Cited by 46
The pharmacokinetics of saccharin in man
Sweatman, T. W., RENWICK, A. G., & Burgess, C. D. (1981) · Xenobiotica · doi:10.3109/00498258109045864 · Cited by 46
Greenblatt, D. J., Divoll, M. K., Soong, M. H., Boxenbaum, H. G., Harmatz, J. S., & Shader, R. I. (1988) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1988.tb03228.x · Cited by 42
Pharmacokinetics and metabolism of antipyrine (phenazone) after intravenous and oral administration.
Eichelbaum, M. F., Ochs, H. R., Roberts, G., & Somogyi, A. A. (1982) · PubMed · Cited by 39
Ryde, E. M., & Ahnfelt, N.-O. (1988) · European Journal of Clinical Pharmacology · doi:10.1007/bf01046706 · Cited by 37
LOBLEY, R. W., Burrows, P. C., Warwick, R., et al. (1990) · Clinical Science · doi:10.1042/cs0790175 · Cited by 33
Pharmacokinetics and Effect of Food on The Bioavailability of Orally Administered Venlafaxine
Troy, S. M., Parker, V. P., HICKS, D. R., Pollack, G. M., & Chiang, S. T. (1997) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1997.tb04270.x · Cited by 33
Ascorbic Acid Absorption in Humans: A Comparison among Several Dosage Forms
Yung, S., Mayersohn, M., & Robinson, J. B. (1982) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600710304 · Cited by 33
Absorption, Metabolism, and Excretion of Oral Testosterone in Humans by Mass Fragmentography
Shinohara, Y., Baba, S., & Kasuya, Y. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-51-6-1459 · Cited by 30
Dreyfuss, J., Shaw, J. M., & Ross, J. J. (1978) · Xenobiotica · doi:10.3109/00498257809056152 · Cited by 29
Metabolism and disposition of14C-granisetron in rat, dog and man after intravenous and oral dosing
Clarke, S. E., Austin, N. E., Bloomer, J. C., et al. (1994) · Xenobiotica · doi:10.3109/00498259409038671 · Cited by 29
Human intravenous pharmacokinetics and absolute oral bioavailability of cefatrizine
Pfeffer, M., Gaver, R. C., & Ximenez, J. (1983) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.24.6.915 · Cited by 26
The Kinetics of Propylthiouracil in Hyperthyroidism
Kampmann, J. P., & Skovsted, L. (1975) · Acta Pharmacologica et Toxicologica · doi:10.1111/j.1600-0773.1975.tb00836.x · Cited by 25
Blood level studies with viloxazine hydrochloride in man.
Bayliss, P. F. C., & Case, D. (1975) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1975.tb01577.x · Cited by 24
Disposition and Pharmacokinetics of Disulfiram and Calcium Carbimide (Calcium Cyanamide)
Brien, J. F., & Loomis, C. W. (1983) · Drug Metabolism Reviews · doi:10.3109/03602538308991384 · Cited by 22
Bioavailability of chlorothiazide from 50, 100, and 250 mg solution doses
Osman, M. A., Patel, R. B., Irwin, D. S., et al. (1982) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.2510030202 · Cited by 21
Pisani, F., Fazio, A., Spina, E., Artesi, C. J., Pisani, B., Russo, M., Trio, R., & Perucca, E. (1986) · Psychopharmacology · doi:10.1007/bf00179180 · Cited by 18
The effect of food and metoclopramide on the pharmacokinetics and side effects of bromocriptine
Kopitar, Z., Vrhovać, B., Povšić, L., Plavšić, F., Francetić, I., & Urbančič, J. (1991) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/bf03189956 · Cited by 16
Single and multiple dose pharmacokinetics of tenidap sodium in healthy subjects.
Gardner, M. J., Wilner, K. D., Hansen, R., Fouda, H. G., & McMahon, G. (1995) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1995.tb04495.x · Cited by 14
Absorption, distribution and excretion of sultopride in man and several animal species
Kobari, T., Iguro, Y., Ito, T., Namekawa, H., Kato, Y., & Yamada, S. (1985) · Xenobiotica · doi:10.3109/00498258509045890 · Cited by 10
Pharmacokinetics of the anti-inflammatory drug ximoprofen in healthy subjects and in disease states
Taylor, I. W., Taylor, T., James, I. M., Doyle, G. D., Dorf, G., Darragh, A. C., & Chasseaud, L. F. (1991) · European Journal of Clinical Pharmacology · doi:10.1007/bf00315147 · Cited by 6
Prueksaritanont, T., & Chiou, W. L. (1987) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.2510080111 · Cited by 3
Cited by
ADMET in silico modelling: towards prediction paradise?
van de Waterbeemd, H., & Gifford, E. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1032 · Cited by 1,863
Martin, Y. C. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0492002 · Cited by 1,020
Rate-Limited Steps of Human Oral Absorption and QSAR Studies
Zhao, Y. H., Abraham, M. H., Le, J., Hersey, A., Luscombe, C. N., Beck, G., Sherborne, B., & Cooper, I. (2002) · Pharmaceutical Research · doi:10.1023/a:1020444330011 · Cited by 717
Self-citationCoexistence of passive and carrier-mediated processes in drug transport
Sugano, K., Kansy, M., Artursson, P., Avdeef, A., Bendels, S., Di, L., Ecker, G. F., Faller, B., Fischer, H., Gerebtzoff, G., et al. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3187 · Cited by 649
BDDCS Applied to Over 900 Drugs
Benet, L. Z., Broccatelli, F., & Oprea, T. I. (2011) · The AAPS Journal · doi:10.1208/s12248-011-9290-9 · Cited by 626
Metadata
- Authors
- Zhao, Y. H., Le, J., Abraham, M. H., Hersey, A., Eddershaw, P. J., Luscombe, C. N., Boutina, D., Beck, G., Sherborne, B., Cooper, I., & Platts, J. A.
- Venue
- Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Published
- 2001-06
- Volume
- 90
- Issue
- 6
- Pages
- 749-784
- ISSN
- 0022-3549 (ISSN-L)
- OpenAlex
- W2157970175
- Cited by
- 526
- References
- 159
- FWCI
- 27.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.